SNCA and Parkinson disease: Transgenic C. elegans strains, BZ555 [egIs1 (dat‐1p::GFP)] and NL5901 [pkIs2386 (unc‐54p::alphasynuclein::YFP + unc‐119(+))] are also used to study the localization of DA neurons and SNCA accumulation, respectively while screening for anti‐PD agents [14].